| Followers | 28 |
| Posts | 4948 |
| Boards Moderated | 0 |
| Alias Born | 09/22/2006 |
Friday, November 22, 2024 8:23:29 AM
The more you know, the less you don't know.
Recent HALO News
- Halozyme Announces Global Collaboration and License Agreement with Takeda to Develop and Commercialize Vedolizumab with ENHANZE® • PR Newswire (US) • 01/08/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 11:56:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 11:55:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 11:55:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/05/2026 09:39:18 PM
- Skye Bioscience Shares Rise on Halozyme Partnership to Advance Obesity Treatment • IH Market News • 01/05/2026 03:01:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 10:39:43 PM
- U.S. FDA Approves RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) Co-Formulated with ENHANZE® for the Treatment of Advanced EGFR-mutated Non-Small Cell Lung Cancer • PR Newswire (US) • 12/18/2025 12:00:00 PM
- Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B • PR Newswire (Canada) • 12/16/2025 06:17:00 PM
- Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B • PR Newswire (US) • 12/16/2025 06:17:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/11/2025 11:16:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/09/2025 09:45:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2025 10:20:13 PM
- Jim Lang Elected to Halozyme's Board of Directors • PR Newswire (US) • 12/08/2025 09:05:00 PM
- Halozyme Wins Preliminary Injunction Against Merck's Keytruda SC in Germany • PR Newswire (US) • 12/04/2025 06:26:00 PM
- Halozyme to Participate in the 8th Annual Evercore Healthcare Conference • PR Newswire (US) • 11/25/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2025 09:06:34 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/18/2025 09:50:00 PM
- Halozyme Completes Acquisition of Elektrofi, Expanding Breadth of Offerings in Drug Delivery • PR Newswire (US) • 11/18/2025 01:50:00 PM
- Merus and Halozyme Enter Global Collaboration and License Agreement to Develop Subcutaneous Formulation of Petosemtamab • PR Newswire (US) • 11/17/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/12/2025 10:58:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 10:17:17 PM
- FDA Approved DARZALEX Faspro® for Adult Patients with High-Risk Smoldering Multiple Myeloma • PR Newswire (US) • 11/07/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2025 01:02:52 PM
- Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $650 Million of Convertible Senior Notes due 2031 and $650 Million of Convertible Senior Notes due 2032 • PR Newswire (US) • 11/07/2025 04:37:00 AM
Rainmaker Worldwide Inc. Announces Settlement Agreement Resolving Legacy Debt Obligation • RAKR • Jan 15, 2026 10:35 AM
Xalles Holdings Announces Management Changes • XALL • Jan 12, 2026 8:46 AM
One World Products Enters 2026 Positioned for Disciplined Growth as Isiah Enterprises • OWPC • Jan 8, 2026 12:22 PM
ConnectM Acquires 40% of Sun Solar, Strengthening Balance Sheet and Expanding National Solar & Storage Footprint in Multi-Billion Dollar U.S. Residential Solar & Storage Market • CNTM • Jan 7, 2026 9:00 AM
EVTV Executes Transformational AZIO AI Acquisition Framework at $3.00 Per Share • EVTV • Jan 6, 2026 7:00 AM
Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace • FITY • Jan 5, 2026 1:00 PM
